Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17848668rdf:typepubmed:Citationlld:pubmed
pubmed-article:17848668lifeskim:mentionsumls-concept:C0060389lld:lifeskim
pubmed-article:17848668lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:17848668lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:17848668lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:17848668lifeskim:mentionsumls-concept:C0242568lld:lifeskim
pubmed-article:17848668lifeskim:mentionsumls-concept:C1441416lld:lifeskim
pubmed-article:17848668lifeskim:mentionsumls-concept:C0870071lld:lifeskim
pubmed-article:17848668lifeskim:mentionsumls-concept:C1514509lld:lifeskim
pubmed-article:17848668lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:17848668lifeskim:mentionsumls-concept:C0449445lld:lifeskim
pubmed-article:17848668pubmed:issue18lld:pubmed
pubmed-article:17848668pubmed:dateCreated2007-9-19lld:pubmed
pubmed-article:17848668pubmed:abstractTextThe Prostate Cancer Prevention Trial (PCPT) demonstrated a 24.8% reduction in the 7-year prevalence of prostate cancer among patients treated with finasteride (5 mg daily) compared with that among patients treated with placebo; however, a 25.5% increase in the prevalence of high-Gleason grade tumors was observed, the clinical significance of which is unknown. One hypothesized explanation for this increase is that finasteride reduced prostate volume, leading to detection of more high-grade tumors due to increased sampling density. This possibility was investigated in an observational reanalysis of the PCPT data, with adjustment for sampling density.lld:pubmed
pubmed-article:17848668pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17848668pubmed:languageenglld:pubmed
pubmed-article:17848668pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17848668pubmed:citationSubsetIMlld:pubmed
pubmed-article:17848668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17848668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17848668pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17848668pubmed:statusMEDLINElld:pubmed
pubmed-article:17848668pubmed:monthSeplld:pubmed
pubmed-article:17848668pubmed:issn1460-2105lld:pubmed
pubmed-article:17848668pubmed:authorpubmed-author:LiuKenneth...lld:pubmed
pubmed-article:17848668pubmed:authorpubmed-author:GannPeter HPHlld:pubmed
pubmed-article:17848668pubmed:authorpubmed-author:CaridesAlexan...lld:pubmed
pubmed-article:17848668pubmed:authorpubmed-author:AndersonKeave...lld:pubmed
pubmed-article:17848668pubmed:authorpubmed-author:DaifotisAnast...lld:pubmed
pubmed-article:17848668pubmed:authorpubmed-author:CohenYael CYClld:pubmed
pubmed-article:17848668pubmed:authorpubmed-author:HeydenNorman...lld:pubmed
pubmed-article:17848668pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17848668pubmed:day19lld:pubmed
pubmed-article:17848668pubmed:volume99lld:pubmed
pubmed-article:17848668pubmed:ownerNLMlld:pubmed
pubmed-article:17848668pubmed:authorsCompleteYlld:pubmed
pubmed-article:17848668pubmed:pagination1366-74lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:meshHeadingpubmed-meshheading:17848668...lld:pubmed
pubmed-article:17848668pubmed:year2007lld:pubmed
pubmed-article:17848668pubmed:articleTitleDetection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial.lld:pubmed
pubmed-article:17848668pubmed:affiliationGamida Cell Ltd, Cell Therapy Technologies, Jerusalem, Israel.lld:pubmed
pubmed-article:17848668pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17848668pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:17848668pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17848668lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17848668lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17848668lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17848668lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17848668lld:pubmed